pubmed-article:14622968 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14622968 | lifeskim:mentions | umls-concept:C0242299 | lld:lifeskim |
pubmed-article:14622968 | lifeskim:mentions | umls-concept:C0020792 | lld:lifeskim |
pubmed-article:14622968 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
pubmed-article:14622968 | lifeskim:mentions | umls-concept:C1171362 | lld:lifeskim |
pubmed-article:14622968 | lifeskim:mentions | umls-concept:C0682969 | lld:lifeskim |
pubmed-article:14622968 | lifeskim:mentions | umls-concept:C0040845 | lld:lifeskim |
pubmed-article:14622968 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:14622968 | lifeskim:mentions | umls-concept:C1515670 | lld:lifeskim |
pubmed-article:14622968 | lifeskim:mentions | umls-concept:C0023688 | lld:lifeskim |
pubmed-article:14622968 | lifeskim:mentions | umls-concept:C2003941 | lld:lifeskim |
pubmed-article:14622968 | lifeskim:mentions | umls-concept:C0037813 | lld:lifeskim |
pubmed-article:14622968 | lifeskim:mentions | umls-concept:C0449445 | lld:lifeskim |
pubmed-article:14622968 | lifeskim:mentions | umls-concept:C0205296 | lld:lifeskim |
pubmed-article:14622968 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:14622968 | pubmed:dateCreated | 2003-11-18 | lld:pubmed |
pubmed-article:14622968 | pubmed:abstractText | The ligand-binding domain (LBD) of the human retinoic acid receptor-related orphan receptor (RORalpha-LBD), expressed in Sf9 cells, was purified and analyzed by electrospray ionization-mass spectrometry (ESI-MS). ESI-MS operated under native conditions showed the presence of a fortuitous ligand with molecular weight 386. Further analysis by gas chromatography-mass spectrometry (GC-MS) allowed the identification of the ligands bound to the LBD. Cholesterol (77%) and 7-dehydrocholesterol (provitamin D(3); 18%) were shown to be the major ligands. A monohydroxylated cholesterol derivative was identified as a minor ligand. In addition, ligand exchange experiments monitored by ESI-MS showed that cholesterol sulfate has a higher affinity for RORalpha-LBD than cholesterol and 25-hydroxycholesterol. Binding of coactivator (CoA) peptide GRIP1P was shown to occur in a stoichiometric manner. Therefore, monitoring of binding of CoAs by mass spectrometry could be used for classification of the ligands as agonist or antagonist molecules. | lld:pubmed |
pubmed-article:14622968 | pubmed:language | eng | lld:pubmed |
pubmed-article:14622968 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14622968 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14622968 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14622968 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14622968 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14622968 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14622968 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14622968 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14622968 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14622968 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14622968 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14622968 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14622968 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14622968 | pubmed:month | Dec | lld:pubmed |
pubmed-article:14622968 | pubmed:issn | 0003-2697 | lld:pubmed |
pubmed-article:14622968 | pubmed:author | pubmed-author:FournierBrigi... | lld:pubmed |
pubmed-article:14622968 | pubmed:author | pubmed-author:BitschFrancis... | lld:pubmed |
pubmed-article:14622968 | pubmed:author | pubmed-author:GeisseSabineS | lld:pubmed |
pubmed-article:14622968 | pubmed:author | pubmed-author:AichholzReine... | lld:pubmed |
pubmed-article:14622968 | pubmed:author | pubmed-author:KallenJoergJ | lld:pubmed |
pubmed-article:14622968 | pubmed:author | pubmed-author:SchlaeppiJean... | lld:pubmed |
pubmed-article:14622968 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14622968 | pubmed:day | 1 | lld:pubmed |
pubmed-article:14622968 | pubmed:volume | 323 | lld:pubmed |
pubmed-article:14622968 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14622968 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14622968 | pubmed:pagination | 139-49 | lld:pubmed |
pubmed-article:14622968 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:meshHeading | pubmed-meshheading:14622968... | lld:pubmed |
pubmed-article:14622968 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:14622968 | pubmed:articleTitle | Identification of natural ligands of retinoic acid receptor-related orphan receptor alpha ligand-binding domain expressed in Sf9 cells--a mass spectrometry approach. | lld:pubmed |
pubmed-article:14622968 | pubmed:affiliation | Central Technologies, Novartis Institutes for Biomedical Research, Lichtstrasse 35, CH-4002 Basel, Switzerland. francis.bitsch@pharma.novartis.com | lld:pubmed |
pubmed-article:14622968 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14622968 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14622968 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14622968 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14622968 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14622968 | lld:pubmed |